1-3 of 3
Bradley W. Blaser, PhD
Close
Sort by
Journal Articles

Mechanism by Which Exogenous Administration of Flt3 Ligand (FL) Expands Natural Killer Cells In Vivo .

Martin Guimond, PhD, Aharon G. Freud, PhD, Hsiaoyin C. Mao, MSc, Bradley W. Blaser, PhD, Gerritt Gerritt Lagemann, MD, Jeffrey B. Vandeusen, PhD, Adrienne Dorrance, PhD, Amy K. Ferketich, PhD, Marta Cavalcanti, MD, Crystal L. Mackall, MD, Michael A. Caligiuri, MD
Journal: Blood
Blood (2007) 110 (11): 2310.
https://doi.org/10.1182/blood.V110.11.2310.2310
Published: 2007
Journal Articles

Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo.

Nicolai Wagtmann, PhD, Pascale Andre, PhD, Stefan Zahn, PhD, Pieter Spee, PhD, Nicolas Anfossi, PhD, Laurent Gauthier, PhD, Bradley W. Blaser, PhD, Michael A. Caligiuri, MD, Marusca Capanni, Loredana Ruggeri, PhD, Andrea Velardi, MD, Francois Romagne, PhD
Journal: Blood
Blood (2007) 110 (11): 582.
https://doi.org/10.1182/blood.V110.11.582.582
Published: 2007
Journal Articles

In Vitro and In Vivo Evidence That the PP2A Inhibitor SET Regulates IFN-γ Production in Monokine-Stimulated Natural Killer Cells.

Rossana Trotta, PhD, Jessica Dal Col, PhD, Jeffrey Allard, II, BS, Paolo Neviani, PhD, Ramasamy Santhanam, PhD, Hsiaoyin Mao, MS, Brian Becknell, PhD, Jianhua Yu, PhD, Aalok Modi, BS, Bradley W. Blaser, PhD, Danilo Perrotti, MD PhD, Michael A. Caligiuri, MD
Journal: Blood
Blood (2006) 108 (11): 928.
https://doi.org/10.1182/blood.V108.11.928.928
Published: 2006